Mapping of topoisomerase II α epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis

Clinical and Experimental Immunology

Volumn 114, Issue 3, 1998, Pages 339-346

  Grigolo, B ^a   Mazzetti, I ^a   Borzi R M ^a   Hickson, I D ^b   Fabbri, M ^c   Fasano, L ^c   Meliconi, R ^a,c   Facchini, A ^a,c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Autoantibodies; Epitope mapping; Idiopathic pulmonary fibrosis; Topoisomerase II

Indexed keywords

AUTOANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA TOPOISOMERASE (ATP HYDROLYSING);

ADULT; AGED; AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; LUNG FIBROSIS; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SEQUENCE HOMOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; AUTOANTIBODIES; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PULMONARY FIBROSIS;

EID: 0031766798     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00747.x     Document Type: Article

References (47)

1. Neu HC. Clinical use of the quinolones. Lancet 1987; ii:1319-22.
2. Shen LL, Perner AG. Mechanism of inhibition of DNA gyrase by analogues of nalidixic acid: the target of the drugs in DNA. Proc Natl Acad Sci USA 1985; 82:307-11.
3. Yang L, Rowe TC, Liu LF. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxin in Simian virus 40-infected monkey cells. Cancer Res 1985; 45:5872-6.
4. Nelson EM, Tewey KM, Liu LF. Mechanism of antitumor drug action: poisoning of mammalian topoisomerase II on DNA by m-AMSA. Proc Natl Acad Sci USA 1984; 81:1361-5.
5. Epstein RJ, Smith PJ. Estrogen-induced potentiation of DNA damage and cytotoxicity in human breast cancer treated with topoisomerase II-interactive antitumor drugs. Cancer Res 1988; 48:297-303.
6. Shero JH, Borwell B, Rothfield NF, Earnshaw WC. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science 1986; 231:737-9.
7. Hoffmann A, Heck MM, Bordwell BJ, Rothfield NF, Earnshaw WC. Human autoantibody to topoisomerase II. Exp Cell Res 1989; 180:409-18.
8. Chan JYH, Becker FF, German J, Ray JH. Altered DNA ligase I activity in Bloom's Syndrome cells. Nature 1987; 325:257-9.
9. Watt PM, Hickson ID. Structure and function of type II DNA topoisomerases. Biochem J 1994; 303:681-95.
10. Meliconi R, Bestagno M, Sturani C et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol 1989; 76:184-9.
11. Meliconi R, Negri C, Borzì RM, Facchini A, Sturani C, Fasano L, Fabbri M, Astaldi Ricotti GCB. Antibodies to topoisomerase II α in idiopathic pulmonary fibrosis. Clin Rheumatol 1993; 12:311-5.
12. Zuklys KL, Szer IS, Szer W. Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis. Clin Exp Immunol 1991; 84:245-9.
13. Chang YH, Hwang J, Shang HF, Tsai ST. Characterization of human DNA topoisomerase II as an autoantigen recognised by patients with IDDM. Diabetes 1996; 45:408-14.
14. Klinman DM, Steinberg AD. Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 1987; 165:1755-60.
15. Tan EM, Chan EKL, Sullivan KF, Rubin RL. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin Immunol Immunopathol 1988; 47:121-41.
16. Abbas AK, Lichtman AH, Pober JS. Self tolerance and autoimmunity. In: Cellular and molecular immunology. 2nd edn. Philadelphia: W.B. Saunders, Co., 1994.
17. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987; 50:819-20.
18. Reeves WH, Pierani A, Chou C, Ng T, Nicastri C, Roeder RG, Sthoeger ZM. Epitopes of the p70 and p80 (Ku) lupus autoantigens. J Immunol 1991; 146:2678-85.
19. Huff JP, Roos G, Peebles CL, Houghten R, Sullivan KF, Tan EM. Insight into native epitopes of proliferating cell nuclear antigen using recombinant DNA protein products. J Exp Med 1990; 172:419-29.
20. Saitta MR, Arnett FC, Keen JD. 60-kDa Ro protein autoepitopes identified using recombinant polypeptides. J Immunol 1994; 152: 4192-202.
21. Meliconi R, Andreone P, Fasano L et al. Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. Thorax 1996; 51:315-7.
22. Watters LC, King TE, Schwartz MI, Waldron JA, Stanford RF, Cherniack RM. A clinical, radiologic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133:97-103.
23. Jenkins JR, Ayton P, Jones T, Davies SL, Simmons DL, Harris AL, Sheer D, Hickson ID. Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acid Res 1992; 20:5587-92.
24. Wells NJ, Addison CM, Fry AM, Ganapathi R, Hickson ID. Serine 1524 is a major site of phosphorylation on human topoisomerase II α protein in vivo and is a substrate for casein kinase II in vitro. J Biol Chem 1994; 269:29746-51.
25. Wasserman RA, Austin CA, Fisher LM, Wang JC. Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II α in yeast. Cancer Res 1993; 53:3591-6.
26. Geysen HM, Rodda SJ, Mason TJ, Tribbick G, Schools PG. Strategies for epitope analysis using peptide synthesis. J Immunol Methods 1987; 102:259-74.
27. Tribbick G. Developments in ELISA: the use of biotinylated peptides in the assessment of antipeptide sera. Am Biotechnol Lab 1993; 11:32.
28. Rost B. PHD: Predicting one-dimensional protein structure by profile based neural networks. Methods Enzymol 1996; 266:525-39.
29. Kabsch I, Sander C. Dictionary of secondary structure of proteins. Biopolymers 1983; 22:2577-637.
30. Pearson WR, Lipman DJ. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 1988; 85:2444-8.
31. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tools. Mol Biol 1990; 215:403-10.
32. Barlow DJ, Edwards MS, Thornton JM. Continuous and discontinuous protein antigenic determinants. Nature 1986; 332:747-8.
33. Male D, Champion B, Cooke A. Antigenity of proteins. In: Advanced immunology. Philadelphia: JB Lippincott Co.. 1987; 8.1-8.9.
34. Habets WJ, Hoet MH, de Jong BAW, van der Kemp A, van Venroij W. Mapping of B cell epitopes on small nuclear ribonucleoproteins that react with human autoimmune and mouse monoclonal antibodies. J Immunol 1989; 143:2560-6.
35. Carson DA. The value of epitope mapping in autoimmune diseases. J Clin Invest 1994; 94:1713.
36. Zuber M, Tan EM, Ryoji M. Involvement of proliferating cell nuclear antigen (PCNA) /cyclin in DNA replication in living cells. Mol Cell Biol 1989; 9:57-66.
37. Tan CK, Sullivan K, Li X, Tan EM, Downey KM, So AS. Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein of DNA polymerase delta. Nucleic Acid Res 1987; 15:9299-308.
38. Dang CV, Tan EM, Traugh JA. Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase. FASEB J 1988; 2:2376-9.
39. Doble ND, Banga JP, Pope R, Lalot E, Kilduff P, McGregor AM. Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunology 1988; 64:23-29.
40. Yamanaka H, Willis EH, Carson DA. Human autoantibodies to poly (adenosinediphosphate-ribose) polymerase recognize crossreactive epitopes associated with the catalytic site of the enzyme. J Clin Invest 1989; 83:180-6.
41. Hopp TP, Woods KR. Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci USA 1981; 78:3824-8.
42. von Mühlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Seminars Arthritis Rheum 1995; 24:323-58.
43. Reiser KM, Last JA. Early cellular events in pulmonary fibrosis. Exp Lung Res 1986; 10:331-55.
44. Selman M, Gonzalez G, Bravo M, Sullivan-Lopez J, Ramos C, Montano M, Barquin N, Vadillo F. Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis. Thorax 1990; 45:451-5.
45. Wallace WA, Howie SE, Krajewski AS, Lamb D. The immunological architecture of B-lymphocyte aggregates in eryptogenic fibrosing alveolitis. J Pathol 1996; 178:323-9.
46. gag protein suggests a possible cause for autoimmunity in systemic sclerosis. Proc Natl Acad Sci USA 1989; 86:8492-6.
47. Ebert SN, Subramanian D, Shtrom SS, Chung IK, Parris DS, Muller MT. Association between the p170 form of human topoisomerase II and progeny viral DNA in cells infected with herpes simplex virus type 1. J Virol 1994; 68:1010-20.